No Data
Johnson & Johnson (JNJ.US) monoclonal antibody therapy achieves Phase 3 clinical primary endpoints significantly delaying high-risk SMM progression.
The American Society of Hematology (ASH) released abstracts of some studies at its 2024 conference.
Express News | Global first BCMA x CD3 bispecific drug Tlachol is launched in China.
Johnson & Johnson Darzalex Shows Efficacy in Early-stage Multiple Myeloma
AI Robot Trader Dumped Microsoft, Amazon Stocks and Went Defensive. Here's What It Bought. -- Barrons.com
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
With 73% Ownership of the Shares, Johnson & Johnson (NYSE:JNJ) Is Heavily Dominated by Institutional Owners